N-Chlorotaurine shows high in vitro activity against promastigotes and amastigotes of Leishmania species

Journal of Medical Microbiology

Volumn 58, Issue 10, 2009, Pages 1298-1302

  Fürnkranz, Ursula ^a   Nagl, Markus ^b   Gottardi, Waldemar ^b   Matt, Ulrich ^a,c   Aspöck, Horst ^a   Walochnik, Julia ^a  

^a MEDICAL UNIVERSITY OF VIENNA   (Austria)

^b INNSBRUCK MEDICAL UNIVERSITY   (Austria)

^c Research Center for Molecular Medicine of the Austrian Academy of Sciences ^*  (Austria)

Author keywords

[No Author keywords available]

Indexed keywords

AMMONIUM CHLORIDE; MONOCHLORAMINE; N CHLOROTAURINE; TAURINE DERIVATIVE; UNCLASSIFIED DRUG;

AMASTIGOTE; ANTIPROTOZOAL ACTIVITY; ARTICLE; CONTROLLED STUDY; HUMAN; HUMAN CELL; IN VITRO STUDY; LEISHMANIA DONOVANI; LEISHMANIA INFANTUM; PRIORITY JOURNAL; PROMASTIGOTE;

AMMONIUM CHLORIDE; ANIMALS; ANTIPROTOZOAL AGENTS; CELL LINE; DRUG SYNERGISM; HUMANS; LEISHMANIA; LEISHMANIA DONOVANI; LEISHMANIA INFANTUM; MACROPHAGES; MONOCYTES; PARASITIC SENSITIVITY TESTS; TAURINE;

EID: 70349305252     PISSN: 00222615     EISSN: None     Source Type: Journal    
DOI: 10.1099/jmm.0.011155-0     Document Type: Article

References (33)

1. Arnitz, R., Sarg, B., Ott, H. W., Neher, A., Lindner, H. & Nagl, M. (2006). Protein sites of attack of N-chlorotaurine in Escherichia coli. Proteomics 6, 865-869. (Pubitemid 43260211)
2. Ashutosh, Sundar, S. & Goyal, N. (2007). Molecular mechanisms of antimony resistance in Leishmania. J Med Microbiol 56, 143-153. (Pubitemid 46302715)
3. Beach, D. H., Holz, G. G., Jr & Anekwe, G. E. (1979). Lipids of Leishmania promastigotes. J Parasitol 65, 201-216.
4. Collin, S., Davidson, R., Ritmeijer, K., Keus, K., Melaku, Y., Kipngetich, S. & Davies, C. (2004). Conflict and kala-azar: determinants of adverse outcomes of kala-azar among patients in southern Sudan. Clin Infect Dis 38, 612-619. (Pubitemid 38333855)
5. Croft, S. L., Sundar, S. & Fairlamb, A. H. (2006). Drug resistance in leishmaniasis. Clin Microbiol Rev 19, 111-126.
6. Eibl, H. (2000). Tödliche Tropenkrankheit jetzt heilbar. http://www.mpibpc.gwdg.de/abteilungen/293/PR/00-01/leish.html (accessed 12 February 2009).
7. 3 (edelfosine) and amphotericin B. Acta Trop 81, 151-157.
8. Fürnkranz, U., Nagl, M., Gottardi, W., Köhsler, M., Aspöck, H. & Walochnik, J. (2008). Cytotoxic activity of N-chlorotaurine on Acanthamoeba spp. Antimicrob Agents Chemother 52, 470-476. (Pubitemid 351170816)
9. Gebre-Hiwot, A., Tadesse, G., Croft, S. L. & Frommel, D. (1992). An in vitro model for screening antileishmanial drugs: the human leukaemia monocyte cell line, THP-1. Acta Trop 51, 237-245.
10. Gottardi, W. & Nagl, M. (2002). Chemical properties of N-chlorotaurine sodium, a key compound in the human defence system. Arch Pharm (Weinheim) 335, 411-421. (Pubitemid 35440043)
11. Gottardi, W. & Nagl, M. (2005). Chlorine covers on living bacteria: the initial step in antimicrobial action of active chlorine compounds. J Antimicrob Chemother 55, 475-482. (Pubitemid 40542586)
12. Gottardi, W., Hagleitner, M. & Nagl, M. (2001). The influence of plasma on the disinfecting activity of the new antimicrobial agent N-chlorotaurine-sodium in comparison with chloramine T. J Pharm Pharmacol 53, 689-697. (Pubitemid 32457819)
13. Gottardi, W., Arnitz, R. & Nagl, M. (2007). N-Chlorotaurine and ammonium chloride: an antiseptic preparation with strong bactericidal activity. Int J Pharm 335, 32-40. (Pubitemid 46482861)
14. Grimm, F., Brun, R. & Jenni, L. (1991). Promastigote infectivity in Leishmania infantum. Parasitol Res 77, 185-191.
15. Hofer, E., Neher, A., Gunkel, A. R. & Nagl, M. (2003). In vitro study on the influence of N-chlorotaurine on the ciliary beat frequency of nasal mucosa. Am J Rhinol 17, 149-152.
16. Hofman, V., Marty, P., Perrin, C., Saint-Paul, M. C., Le Fichoux, Y., Michiels, J. F., Glaichenhaus, N., Pratlong, F. & Hofman, P. (2000). The histological spectrum of visceral leishmaniasis caused by Leishmania infantum MON-1 in acquired immune deficiency syndrome. Hum Pathol 31, 75-84. (Pubitemid 30054391)
17. Kontny, E., Grabowska, A., Kowalczewski, J., Kurowska, M., Janicka, I., Marcinkiewicz, J. & Maśliński, W. (1999). Taurine chloramine inhibition of cell proliferation and cytokine production by rheumatoid arthritis fibroblast-like synoviocytes. Arthritis Rheum 42, 2552-2560. (Pubitemid 30327171)
18. Marcinkiewicz, J., Grabowska, A., Bereta, J. & Stelmaszynska, T. (1995). Taurine chloramine, a product of activated neutrophils, inhibits in vitro the generation of nitric oxide and other macrophage inflammatory mediators. J Leukoc Biol 58, 667-674. (Pubitemid 26033855)
19. Mathur, P., Samantaray, J. C., Vajpayee, M. & Samanta, P. (2006). Visceral leishmaniasis/human immunodeficiency virus co-infection in India: the focus of two epidemics. J Med Microbiol 55, 919-922. (Pubitemid 43974699)
20. Nagl, M. & Gottardi, W. (1996). Enhancement of the bactericidal efficacy of N-chlorotaurine by inflammation samples and selected N-H compounds. Hyg Med 21, 597-605. (Pubitemid 26379744)
21. Nagl, M., Larcher, C. & Gottardi, W. (1998a). Activity of N-chlorotaurine against herpes simplex- and adenoviruses. Antiviral Res 38, 25-30. (Pubitemid 28182286)
22. Nagl, M., Miller, B., Daxecker, F., Ulmer, H. & Gottardi, W. (1998b). Tolerance of N-chlorotaurine, an endogenous antimicrobial agent, in the rabbit and human eye - a phase I clinical study. J Ocul Pharmacol Ther 14, 283-290. (Pubitemid 28287605)
23. Nagl, M., Pfausler, B., Schmutzhard, E., Fille, M. & Gottardi, W. (1998c). Tolerance and bactericidal action of N-chlorotaurine in a urinary tract infection by an omniresistant Pseudomonas aeruginosa. Zentralbl Bakteriol 288, 217-223.
24. Nagl, M., Hess, M. W., Pfaller, K., Hengster, P. & Gottardi, W. (2000). Bactericidal activity of micromolar N-chlorotaurine: evidence for its antimicrobial function in the human defense system. Antimicrob Agents Chemother 44, 2507-2513. (Pubitemid 30650903)
25. Nagl, M., Lass-Floerl, C., Neher, A., Gunkel, A. R. & Gottardi, W. (2001). Enhanced fungicidal activity of N-chlorotaurine in nasal secretion. J Antimicrob Chemother 47, 871-874. (Pubitemid 32519837)
26. Nagl, M., Nguyen, V. A., Gottardi, W., Ulmer, H. & Höpfl, R. (2003). Tolerability and efficacy of N-chlorotaurine in comparison with chloramine T for the treatment of chronic leg ulcers with a purulent coating: a randomized phase II study. Br J Dermatol 149, 590-597. (Pubitemid 37281593)
27. Park, E., Schuller-Levis, G. & Quinn, M. R. (1995). Taurine chloramine inhibits production of nitric oxide and TNF-α in activated RAW 264.7 cells by mechanisms that involve transcriptional and translational events. J Immunol 154, 4778-4784.
28. Reeves, E. P., Nagl, M., O'Keeffe, J., Kelly, J. & Kavanagh, K. (2006). Effect of N-chlorotaurine on Aspergillus, with particular reference to destruction of secreted gliotoxin. J Med Microbiol 55, 913-918. (Pubitemid 43974698)
29. Singh, S. P., Reddy, D. C., Rai, M. & Sundar, S. (2006). Serious underreporting of visceral leishmaniasis through passive case reporting in Bihar, India. Trop Med Int Health 11, 899-905. (Pubitemid 43846450)
30. Sundar, S. & Rai, M. (2005). Treatment of visceral leishmaniasis. Expert Opin Pharmacother 6, 2821-2829.
31. Teuchner, B., Nagl, M., Schidlbauer, A., Ishiko, H., Dragosits, E., Ulmer, H., Aoki, K., Ohno, S., Mizuki, N. & other authors (2005). Tolerability and efficacy of N-chlorotaurine in epidemic keratoconjunctivitis - a double-blind, randomized, phase-2 clinical trial. J Ocul Pharmacol Ther 21, 157-165.
32. Yardley, V., Croft, S. L., De Doncker, S., Dujardin, J. C., Koirala, S., Rijal, S., Miranda, C., Llanos-Cuentas, A. & Chappuis, F. (2005). The sensitivity of clinical isolates of Leishmania from Peru and Nepal to miltefosine. Am J Trop Med Hyg 73, 272-275. (Pubitemid 41278697)
33. Yazdanbakhsh, M., Eckmann, C. M. & Roos, D. (1987). Killing of schistosomula by taurine chloramine and taurine bromamine. Am J Trop Med Hyg 37, 106-110. (Pubitemid 17155350)